We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Five Prime

News List

Amgen Completes Five Prime Acquisition contractpharma
April 19, 2021
Amgen has completed its acquisition of Five Prime Therapeutics for approximately $1.9 billion in cash. This acquisition adds Five Prime's innovative pipeline of immuno-oncology and targeted cancer therapies to Amgen's oncology portfolio.
Healthcare industry reported 119 deals worth $10.8 billion in March 2021 expresspharma
April 08, 2021
In March 2021, the healthcare industry reported 119 deals worth $10.8 billion as compared to the last 12-month average (March 2020 to February 2021) of 94 deals worth $20 billion.
Amgen to Acquire Five Prime Therapeutics for $1.9B contractpharma
March 05, 2021
Amgen entered an agreement to acquire Five Prime Therapeutics for approximately $1.9 billion in cash. This acquisition adds Five Prime's innovative pipeline of immuno-oncology and targeted cancer therapies to Amgen's oncology portfolio.
Five Prime to cut workforce by 20 percent, sharpen focus on clinical programmes firstwordpharma
January 17, 2019
Five Prime Therapeutics announced restructuring plans that will involve eliminating 41 jobs, representing about 20 percent of its current headcount, mainly in the areas of research, pathology and manufacturing.